Loading...

Elanco Animal Health Incorporated

ELANNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.93
$0.25(1.70%)

Fundamental Analysis of Elanco Animal Health Incorporated (ELAN)

Comprehensive financial metrics and ratios analysis
EPS (TTM)
$0.75
P/E Ratio
19.91
ROE
0.06%
Net Margin
0.08%

Key Financial Metrices

Valuation Metrics

4 metrics
Market CapTotal market value of outstanding shares
$7.41B
Shares OutstandingTotal number of shares issued
$496.65M
Book Value/ShareNet worth per share
$12.83
Revenue/ShareAnnual revenue per share
$8.94

Profitability Metrics

6 metrics
EPS (TTM)Earnings per share trailing twelve months
$0.75
Net MarginNet income as percentage of revenue
8.43%
Operating MarginOperating income as percentage of revenue
5.40%
ROEReturn on shareholders' equity
5.99%
ROAReturn on total assets
2.88%
ROCEReturn on capital employed
2.05%

Cash Flow Metrics

3 metrics
Free Cash Flow/ShareCash generated per share after capex
$0.69
Cash/ShareCash and equivalents per share
$0.98
FCF YieldFree cash flow as percentage of market cap
4.58%

Dividend Metrics

2 metrics
Dividend/ShareAnnual dividend payment per share
-
Dividend YieldAnnual dividend as percentage of stock price
-
Financial Ratios Analysis data is not available for ELANFinancial Ratios Analysis details for ELAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Sector Benchmarking data is not available for ELANSector Benchmarking details for ELAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Elanco Animal Health Incorporated Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Elanco Animal Health Incorporated. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Elanco Animal Health Incorporated's unique business strengths and challenges.

Key Financial Metrics for Elanco Animal Health Incorporated

For Elanco Animal Health Incorporated, essential financial indicators include EPS 0.75, PE 19.91, and ROE 0.06. These key ratios reveal insights into Elanco Animal Health Incorporated's profitability, valuation, and operational health. Understanding these metrics enables you to compare Elanco Animal Health Incorporated with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Elanco Animal Health Incorporated

Metrics like Net Margin 8.43% and ROA 2.88% shed light on how well Elanco Animal Health Incorporated is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Elanco Animal Health Incorporated can sustain its operations and continue growing in the future.

Valuation and Market Position of Elanco Animal Health Incorporated

Using ratios such as P/B Ratio 1.16 and PEG Ratio 1.68, investors can assess whether Elanco Animal Health Incorporated is appropriately valued based on its financials and growth potential. These figures, combined with Elanco Animal Health Incorporated's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Elanco Animal Health Incorporated

Financial health indicators, such as Debt/Equity Ratio 0.69 and Cash Flow $0.69, provide a snapshot of Elanco Animal Health Incorporated's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Elanco Animal Health Incorporated, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Elanco Animal Health Incorporated

Investing in Elanco Animal Health Incorporated based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Elanco Animal Health Incorporated focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;